After hours
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Disposition
Calculated transaction value
$423.28K

Ramsay David A EVP, President, Drug Delivery

Transaction date Jun 30, 2026
Public filing date Jul 2, 2026
Filing lag Filed 2 days later

HALO daily price context

Close on/before transaction
$78.27 Jun 30, 2026
First close after public filing
$80.78 Jul 6, 2026
30-day return after filing
+1.84% Through Aug 3, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
5,408 shares @ $78.27
SEC ownership
Direct
Transaction code
F
Form
4
Filing identifier
0001159036-26-000096
Filing cohort

Transactions in this filing

Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$423.28K
Buys / sales
0 / 0
Transactions reported in the same official filing
Issuer Transaction Traded Value
Halozyme Therapeutics, Inc. HALO Award Jul 1, 2026 $0
Halozyme Therapeutics, Inc. HALO Award Jul 1, 2026 $0
Halozyme Therapeutics, Inc. HALO Exercise Jun 30, 2026 $0
Halozyme Therapeutics, Inc. HALO Current Disposition Jun 30, 2026 $423.28K
Halozyme Therapeutics, Inc. HALO Exercise Jun 30, 2026 $0